Epigral Limited

    Jurisdiction
    India
    ISIN
    INE071N01016 (EPIGRAL.NS)
    Sectors
    1. Basic Materials
    2. Chemicals

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    0 / 7

    Profile

    Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. Read full profile

    Fundamentals

    Net revenue
    €251.43M
    Gross margin
    44.3%
    EBIT
    €65.94M
    EBIT margin
    26.2%
    Net income
    €35.27M
    Net margin
    14.0%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    ₹3.50
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications